Zydus Lifesciences Limited (BOM:532321)
India · Delayed Price · Currency is INR 1,172.00
+5.00 (0.43%)
At close: Oct 28, 2026
Zydus Lifesciences Stock Forecast
Stock Price Forecast
According to 29 analysts polled by S&P Global, Zydus Lifesciences stock has a consensus rating of "Hold" and an average price target of ₹1,221. The average 1-year stock price forecast is 4.18% higher than the current stock price, while the lowest is ₹800.00 (-31.74%) and the highest is ₹1,457 (+24.36%).
Price Target: ₹1,221 (+4.18%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Zydus Lifesciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 8 | 8 | 8 |
| Buy | 9 | 9 | 9 | 7 | 7 | 7 |
| Hold | 10 | 10 | 10 | 8 | 9 | 8 |
| Sell | 2 | 2 | 2 | 4 | 3 | 3 |
| Strong Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Total | 30 | 30 | 31 | 30 | 30 | 29 |
Financial Forecast
Revenue This Year
318.27B
from 271.48B
Increased by 17.23%
Revenue Next Year
353.33B
from 318.27B
Increased by 11.02%
EPS This Year
40.31
from 54.00
Decreased by -25.35%
EPS Next Year
49.89
from 40.31
Increased by 23.78%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.